Chloroplast-derived anthrax and other vaccine antigens: Their immunogenic and immunoprotective properties

Expert Review of Vaccines

Volumn 5, Issue 6, 2006, Pages 839-849

  Kamarajugadda, Sushama ^a   Daniell, Henry ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Anthrax vaccine; Chloroplast genetic engineering; Genetically modified crops; Immunization; Mucosal immunity; Oral delivery; Protective antigens; Systemic immunity; Vaccines

Indexed keywords

ALUMINUM HYDROXIDE; AMEBIASIS VACCINE; ANTHRAX TOXIN; ANTHRAX VACCINE; BACTERIAL ANTIGEN; BACTERIAL VACCINE; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PLAGUE VACCINE; PLANT ANTIGEN; PROTOZOAL VACCINE; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; ROTAVIRUS VACCINE; TETANUS TOXIN; VIRUS VACCINE;

ADJUVANT THERAPY; AMEBIASIS; ANTHRAX; ANTIGEN EXPRESSION; AVIAN INFLUENZA; BACILLUS ANTHRACIS; CHLOROPLAST; CHOLERA; CLINICAL TRIAL; DENGUE; DRUG EFFICACY; GENE THERAPY; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MALARIA; MENINGITIS; NONHUMAN; PLAGUE; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSGENIC PLANT; TYPHOID FEVER; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; YELLOW FEVER;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; CHLOROPLASTS; HUMANS; IMMUNOLOGIC FACTORS; PLANTS, GENETICALLY MODIFIED;

EID: 33845894440     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.5.6.839     Document Type: Review

References (69)

1. Lamphear BJ, Streatfield SJ, Jilka JM et al. Delivery of subunit vaccines in maize seed. J. Control. Release 85, 169-180 (2002).
2. Daniell H, Cohill P, Kumar S, Dufourmantel N, Chloroplast genetic engineering. In: Molecular Biology and Biotechnology of Plant Organelles. Daniell H, Chase C (Ed.). Kluwer Academic Publishers, Dordrecht, The Netherlands 443-490 (2004).
3. Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6, 219-226 (2001).
4. Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8, 324-329 (2002).
5. Koprowski H, Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine 19, 2735-2741 (2001).
6. De Cosa B, Moar W, Lee SB, Miller M, Daniell H. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19, 71-74 (2001). •• Reports the highest expression level of any foreign protein ever expressed in tranasgenic plants and the first expression of a bacterial operon in plants, thereby facilitating expression of multivalent vaccines. Therefore, this article was featured on the cover of Nature Biotechnology.
7. Devine AL, Daniell H. Chloroplast genetic engineering for enhanced agronomic traits and expression of proteins for medical/industrial applications. In: Plastids. Moller SG (Ed.). Blackwell Publishing. 13, 283-323 (2004).
8. Grevich J, Daniell H. Chloroplast genetic engineering: recent advances and future perspectives. Crit. Rev. Plant Sci. 24, 83-108 (2005).
9. Fagard M, Vaucheret H. (Trans) gene silencing in plants: how many mechanisms? Annu. Rev. Plant Physiol. Plant Mol. Biol. 51, 167-194 (2000).
10. Lee SB, Kwon HB, Kwon SJ et al. Accumulation of trehalose within transgenic chloroplasts confers drought tolerance. Mol Breed. 11, 1-13 (2003).
11. Dhingra A, Portis AR, Daniell H. Enhanced translation of chloroplast-expressed RbcS gene restores small subunit levels and photosynthesis in nuclear antisense RbcS plants. Proc. Natl Acad. Sci. USA 101, 6315-6320 (2004).
12. Hagemann R. The sexual inheritance of plant organelles. In: Molecular Biology and Biotechnology of Plant Organelles. Daniell H, Chase C (Ed.). Springer Publishers, Dordrecht, The Netherlands 93-113 (2004).
13. Daniell H. Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20, 581-586 (2002).
14. Ruiz ON, Daniell H. Engineering cytoplasmic male sterility via the chloroplast genome by the expression of β-ketothiolase. Plant Physiol. 138, 1232-1246 (2005). •• Reports a novel method of engineering cytoplasmic male sterility in plants. In addition to maternal inheritance of chloroplast genomes, this is yet another failsafe method of containing trasngene escape via pollen. Therefore, this article was featured on the cover of Plant Physiology and highlighted in Nature and Trends in Plant Science.
15. Quesada-Vergas T, Ruiz ON, Daniell H. Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation. Plant Physiol. 138, 1746-1762 (2005).
16. Ruiz ON, Hussein HS, Terry N, Daniell H. Phytoremediation of organomercurial compounds via chloroplast genetic engineering. Plant Physiol. 132, 1344-1352 (2003).
17. Daniell H, Carmona-Sanchez O, Burns B. Chloroplast-derived antibodies, biopharmaceuticals and eedible vaccines. In: Molecular Farming. Schillberg S, Wiley VCH (Ed.). Verlag publishers, Germany 113-133 (2004).
18. Fernandez-San Millan A, Mingeo-Castel AM, Miller M, Daniell H. A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. 1, 71-79 (2003).
19. Leelavathi S, Reddy VS. Chloroplast expression of His-tagged GUS fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol. breed. 11, 49-58 (2003).
20. Staub JM, Garcia B, Graves J et al. High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18, 333-338 (2000). •• Reports expression of a fully functional human blood protein in transgenic chloroplasts with proper folding and disulfide bonds.
21. Daniell H, Chebolu S, Kumar S, Singleton M, Falconer R. Chloroplast-derived vaccine antigens and other therapeutic proteins. Vaccine 23, 1779-1783 (2005).
22. Daniell H, Kumar S, Dufourmantel N. Breakthrough in chloroplast genetic engineering of agronomically important crops. Trends Biotechnol. 23, 238-245 (2005).
23. Daniell H, Lee SB, Panchal T, Wiebe PO. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 1001-1009 (2001). •• First report of a vaccine antigen expressed in transgenic chloroplasts. Formation of disulfide bonds and assembly of pentamers were demonstrated by polyacrylamide gel electrophoresis (PAGE) and GM1 binding assays.
24. Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C. Anthrax toxIn: a tripartite lethal combination. FEBS Lett. 531, 384-388 (2002).
25. Collier RJ, Young JA. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19, 45-70 (2003).
26. Galloway DR, Baillie L. DNA vaccines against anthrax. Expert Opin. Biol. Ther. 4, 1661-1667 (2004).
27. Aziz MA, Singh S, Kumar PA, Bhatnagar R. Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem. Biophys. Res. Commun. 299, 345-351 (2002).
28. Aziz MA, Sikriwal D, Singh S, Jarugula S, Kumar PA, Bhatnagar R. Transformation of an edible crop with the pagA gene of Bacillus anthracis. FASEB J. 19, 1501-1503 (2005).
29. Watson J, Koya V, leppla SH, Daniell H. Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-feed/feed crop. Vaccine 22(31-32), 4374-4384 (2004). •• First report of a functional vaccine antigen against a pathogen used in bioterrorism. Reports high expression levels of anthrax protective antigen, confirms its biological functionality in in vitro assays and also shows the intactness and stability of full length PA protein within chloroplasts.
30. Koya V, Moayeri M, Leppla SH, Daniell H. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73(12), 8266-8274 (2005). •• Reports exceptionally high expression levels of chloroplast-derived anthrax protective antigen and immunogenic and immunoprotective properties in immunized mice. This article has been highlighted by numerous articles in the public press and broadcasting stations, including the Discovery channel and scientific journals.
31. Kim TG, Galloway DR, Langridge WH. Synthesis and assembly of anthrax lethal factor-cholera toxin B-subunit fusion protein in transgenic potato. Mol. Biotechnol. 28, 175-183 (2004).
32. Carter JE III, Yu J, Choi NW et al. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. Mol. Biotechnol. 32(1), 1-15 (2006).
33. Arkawa T, Yu J, Chong DK, Hough J, Engen PC, Langridge WH. A plant-based cholera toxin B subunit-insulin fusion protein against the development of autoimmune diabetes. Nat. Biotechnol. 16, 934-938 (1998). •• First report of oral tolerance from a plant-derived autoantigen.
34. Mason HS, Haq TA, Clements JD, Arntzen CA. Edible vaccine protects mice against E. coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16, 1336-1343
35. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4, 607-609. •• First report of human clinical trials conducted using a plant-derived vaccine antigen.
36. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield SJ. Immunogenisity of recombinant LT-B delivered orally to human in transgenic corn.Vaccine 22, 4385-4389 (2004)
37. Molina A, Hervás-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi A. High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2(2), 141-153 (2004). •• First report of animal vaccine via the chloroplast genome, confirming expression and immunogenic properties in mice.
38. Limaye A, Koya V, Mohtashem S, Daniell H. Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 20(7), 959-961 (2006). •• First demonstration of the transmucosal activity of plant-derived CTB in delivering a foreign protein to target tissues via the circulatory system in orally fed mice and confirmation of protection of recombinant proteins from proteases/pepdidases by bioencapsulation within plant cells.
39. Kang TJ, Loc NH, Jang MO et al. Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res. 12(6), 683-691 (2003).
40. Kumar S, Dhingra A, Daniell H. Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots and leaves confers enhanced salt tolerance. Plant Physiol. 136, 2843-2854 (2004) •• First chloroplast transformation via somatic embryogenesis using nongreen tissues for the expression of recombinant proteins.
41. Kanamoto H, Yamashita A, Asao H et al., Efficient and stable transformation of Lactuca sativa L.cv. Cisco (lettuce) Plastids. Transgenic Res. 15, 205-217 (2006).
42. Lelivelt C, McCabe M, Newell C et al. Stable Plastid Transformation in Lettuce (Lactuca sativa L.). Plant Mol. Bio. 58, 763 (2005).
43. Heath JP. Epithelial cell migration in the intestine. Cell Biol. Int. 20, 139-146 (1996).
44. Alvarez ML, Pinyerd HL, Crisantes JD et al. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24(14), 2477-2490 (2005).
45. Santi L, Giritch A, Roy CJ et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc. Natl Acad. Sci. USA 103(4), 861-866 (2006).
46. Langeveld JP, Casal JI, Cortes E et al. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12, 1473-1480 (1994).
47. Langeveld JP, Brennan FR, Martinez-Torrecuadrada JL et al. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 19, 3661-3670 (2001).
48. Gil F, Brun A, Wigdorovitz A et al. High-yield expression of a viral peptide in transgenic plants. FEBS Lett. 488, 13-17 (2001).
49. Molina A, Veramendi J, Hervas-Stubbs S. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342, 266-275 (2005).
50. Olszewska W, Openshaw PJ. Mucosal vaccination. In: Kaufmann SHE (Ed.). Novel Vaccination strategies. Wiley-VCH, Weinheim, Germany 342-365 (2005).
51. Dong JL, Liang BG, Jin YS, Zhang WJ, Wang T. Oral immunization with pBs VP6-transgenic alfalfa protects mice against rotavirus infection. Virology 339, 153-163 (2005).
52. Saldana S, Esquivel GF, Olivera FTJ et al. Production of rotavirus- like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunol. 19, 42-53 (2006).
53. Yu J, Langridge W. Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. 12, 163-169 (2003).
54. Choi NW, Estes MK, Langridge WH. Synthesis and assembly of a cholera toxin B subunit- rotavirus VP7 fusion protein in transgenic potato. Mol. Biotechnol. 31, 193-202 (2005).
55. Choi NW, Estes MK, Langridge WH. Synthesis of a ricin toxin B subunit- rotavirus VP7 fusion protein in potato. Mol. Biotechnol. 32, 117-128 (2006).
56. Wu YZ, Li JT, Mou ZR et al. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology 313, 337-342 (2003).
57. Kim TG, Langridge WH. Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Rep. 21, 884-890 (2003).
58. Birch-Machin I, Newell CA, Hibberd JM, Gray JC. Accumulation of rotavirus VP6 protein in chloroplasts of transplastomic tobacco is limited by protein stability. Plant Biotechnol. 2, 261-270 (2004).
59. Huston CD, Petri WA Jr. Host-pathogen interaction in Amebiasis and progress vaccine development. Eur. J. Clin. Microbiol. Infect. Dis. 17, 601-614 (1998).
60. Houpt E, Barroso L, Lockhart L et al. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNAc lectin. Vaccine 22, 11-17 (2004).
61. Chebolu S, Daniell H. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogeicity in mice towards vaccine development for amoebiasis. Plant Biotechnol. J. (In Press) (2006).
62. Snow MJ, Stanley SL Jr. Recent progress in vaccines for amebiasis. Arch. Med. Res. 37(2), 280-287 (2006).
63. Glenz K, Bouchon B, Stehle T, Wallich R, Simon MM, Warzecha H. Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat. Biotechnol. 24, 76-77 (2006).
64. Jansen RK, Kaittanis C, Lee SB et al. Phylogenetic analysis of Vitis (Vitaceae) based on complete chloroplast genome sequences: effects of taxon sampling and phylogenetic methods on resolving relationships among rosids. BMC Evol. Biol. 6, 32 (2006).
65. Daniell H, Lee SB, Grevich J et al. Complete chloroplast genome sequences of Solanum bulbocastanum, Solanum lycopersicum and comparative analysis with other Solanaceae genomes. Theor. Appl. Genet. 112, 1503-1518 (2006).
66. Saski C, Lee SB, Daniell H et al. Complete chloroplast genome sequence of Glycine max and comparative analyses with other legume genomes. Plant Mol. Biol. 59, 309-322 (2005).
67. Ruhlman T, Lee SB, Jansen RK et al. Complete plastid genome sequence of Daucus carota: implications for biotechnology and phylogeny of angiosperms. BMC Genomics 7, 224 (2006).
68. Tregoning JS, Nixon P, Kuroda H et al. Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res. 31(4), 1174-1179 (2003).
69. World Health Organization www.who.int/en/